CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

February 20, 2024 | Pratt School of Engineering

Harnessing Skin Cancer Genes to Heal Hearts

January 30, 2024 | Department of Molecular Genetics & Microbiology

Dr. Adrianna San Roman Joins MGM Faculty

January 22, 2024

Gersbach part of panel discussion at Global Healthspan Summit

CAGT Director Charlie Gersbach was part of a panel discussion, "Growing a Healthier Future Together," at the Global Healthspan Summit.  Watch the discussion on YouTube